Marit Hellebostad

1.3k total citations
37 papers, 929 citations indexed

About

Marit Hellebostad is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marit Hellebostad has authored 37 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 14 papers in Public Health, Environmental and Occupational Health and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marit Hellebostad's work include Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Acute Myeloid Leukemia Research (7 papers). Marit Hellebostad is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Acute Myeloid Leukemia Research (7 papers). Marit Hellebostad collaborates with scholars based in Norway, Denmark and Sweden. Marit Hellebostad's co-authors include Erik Forestier, Kjeld Schmiegelow, Mats Heyman, S Söderhäll, Mervi Taskinen, Jakob Kristinsson, P Hågå, Ólafur G. Jónsson, Päivi M. Lähteenmäki and P. Mary Cotes and has published in prestigious journals such as British Journal of Haematology, Leukemia and Archives of Disease in Childhood.

In The Last Decade

Marit Hellebostad

35 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marit Hellebostad Norway 16 475 413 389 160 134 37 929
Hester A. de Groot‐Kruseman Netherlands 16 662 1.4× 457 1.1× 402 1.0× 173 1.1× 121 0.9× 43 988
Thuan Chong Quah Singapore 15 474 1.0× 171 0.4× 452 1.2× 193 1.2× 162 1.2× 56 874
Stéphane Ducassou France 20 422 0.9× 242 0.6× 431 1.1× 227 1.4× 197 1.5× 80 1.1k
Anja Borgmann‐Staudt Germany 17 658 1.4× 306 0.7× 447 1.1× 132 0.8× 103 0.8× 55 1.0k
Roberto Rivera‐Luna Mexico 16 326 0.7× 141 0.3× 280 0.7× 176 1.1× 129 1.0× 67 808
Caroline A. Hastings United States 14 422 0.9× 216 0.5× 474 1.2× 151 0.9× 179 1.3× 42 953
Margaret Masterson United States 15 263 0.6× 600 1.5× 137 0.4× 139 0.9× 285 2.1× 41 930
G H Reaman United States 13 503 1.1× 378 0.9× 310 0.8× 160 1.0× 118 0.9× 17 915
Ólafur Gísli Jónsson Iceland 15 543 1.1× 250 0.6× 427 1.1× 167 1.0× 133 1.0× 39 798
Jennifer L. McNeer United States 15 479 1.0× 240 0.6× 445 1.1× 287 1.8× 150 1.1× 42 927

Countries citing papers authored by Marit Hellebostad

Since Specialization
Citations

This map shows the geographic impact of Marit Hellebostad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Hellebostad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Hellebostad more than expected).

Fields of papers citing papers by Marit Hellebostad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit Hellebostad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Hellebostad. The network helps show where Marit Hellebostad may publish in the future.

Co-authorship network of co-authors of Marit Hellebostad

This figure shows the co-authorship network connecting the top 25 collaborators of Marit Hellebostad. A scholar is included among the top collaborators of Marit Hellebostad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marit Hellebostad. Marit Hellebostad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hellebostad, Marit, et al.. (2021). Alloimmunization in transfused patients with constitutional anemias in Norway. Transfusion and Apheresis Science. 60(5). 103257–103257. 4 indexed citations
2.
Taskinen, Mervi, Mette Levinsen, Matteo Bottai, et al.. (2016). The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols. Pediatric Blood & Cancer. 64(2). 242–249. 9 indexed citations
3.
Söderhäll, S, Johan Arvidson, Erik Forestier, et al.. (2015). Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. Haematologica. 101(1). 68–76. 113 indexed citations
4.
Panagopoulos, Ioannis, Ludmila Gorunova, Gitte Kerndrup, et al.. (2015). Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?. Experimental Hematology and Oncology. 5(1). 8–8. 5 indexed citations
5.
Gustafsson, Britt, Marit Hellebostad, Marianne Ifversen, Birgitta Sander, & Henrik Hasle. (2011). Acute Respiratory Failure in 3 Children With Juvenile Myelomonocytic Leukemia. Journal of Pediatric Hematology/Oncology. 33(8). e363–e367. 4 indexed citations
6.
Skram, Marius Kurås, et al.. (2011). En 15 måneder gammel jente med feber og pancytopeni. Tidsskrift for Den norske legeforening. 131(24). 2482–2486. 5 indexed citations
7.
Schaffer, Lana, Ole Kristoffer Olstad, Anne Grete Bechensteen, et al.. (2010). STRIKING DECREASE IN THE TOTAL PRECURSOR B-CELL COMPARTMENT DURING EARLY CHILDHOOD AS EVIDENCED BY FLOW CYTOMETRY AND GENE EXPRESSION CHANGES. Pediatric Hematology and Oncology. 27(1). 31–45. 17 indexed citations
8.
Schmiegelow, Kjeld, Erik Forestier, Marit Hellebostad, et al.. (2010). EDUCATIONAL REPORT Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
9.
Schmiegelow, Kjeld, Erik Forestier, Marit Hellebostad, et al.. (2009). Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia. 24(2). 345–354. 272 indexed citations
10.
Palle, Josefine, Britt‐Marie Frost, Henrik Hasle, et al.. (2008). Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia. Anti-Cancer Drugs. 20(1). 7–14. 14 indexed citations
11.
Palle, Josefine, et al.. (2006). Etoposide pharmacokinetics in children treated for acute myeloid leukemia. Anti-Cancer Drugs. 17(9). 1087–1094. 21 indexed citations
12.
Palle, Josefine, Britt‐Marie Frost, Curt Peterson, et al.. (2006). Doxorubicin pharmacokinetics is correlated to the effect of induction therapy in children with acute myeloid leukemia. Anti-Cancer Drugs. 17(4). 385–392. 34 indexed citations
13.
Palle, Josefine, Britt‐Marie Frost, Erik Forestier, et al.. (2005). Cellular drug sensitivity in MLL-rearranged childhood acute leukemia is correlated to partner genes and cell lineage : On behalf of the Nordic Society for Paediatric Haematology and Oncology. British Journal of Haematology. 129(2). 1 indexed citations
14.
Palle, Josefine, B‐M Frost, Erik Forestier, et al.. (2005). Cellular drug sensitivity in MLL‐rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. British Journal of Haematology. 129(2). 189–198. 24 indexed citations
15.
Moe, Peter Johan, Are Holen, Anders Glomstein, et al.. (1997). Long-Term Survival and Quality of Life in Patients Treated with a National all Protocol 15–20 Years Earlier: IDM/HDM and Late Effects?. Pediatric Hematology and Oncology. 14(6). 513–524. 35 indexed citations
16.
Hågå, P, S Halvorsen, Andrew Whitelaw, et al.. (1993). Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.. Archives of Disease in Childhood. 69(1 Spec No). 19–23. 71 indexed citations
17.
Hellebostad, Marit, Truls Sanengen, & S Halvorsen. (1990). Variations in erythropoiesis throughout a lifetime. Annals of Hematology. 61(6). 358–363. 3 indexed citations
18.
Hellebostad, Marit, et al.. (1990). Serum immunoreactive erythropoietin in children with acute leukaemia at various stages of disease — and the effects of treatment. European Journal Of Haematology. 44(3). 159–164. 16 indexed citations
19.
Cotes, P. Mary, et al.. (1989). An immunological cross‐reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay. British Journal of Haematology. 73(2). 265–268. 14 indexed citations
20.
Hellebostad, Marit, P Hågå, & P. Mary Cotes. (1988). Serum immunoreactive erythropoietin in healthy normal children. British Journal of Haematology. 70(2). 247–250. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hester A. de Groot‐Kruseman Breakdown of academic impact, for papers by Thuan Chong Quah Breakdown of academic impact, for papers by Stéphane Ducassou Breakdown of academic impact, for papers by Anja Borgmann‐Staudt Breakdown of academic impact, for papers by Roberto Rivera‐Luna Breakdown of academic impact, for papers by Caroline A. Hastings Breakdown of academic impact, for papers by Margaret Masterson Breakdown of academic impact, for papers by G H Reaman Breakdown of academic impact, for papers by Ólafur Gísli Jónsson Breakdown of academic impact, for papers by Jennifer L. McNeer
Rankless by CCL
2026